Skip to content
The Nexus
DossierENTITY

Inovio Pharmaceuticals

Coverage of Inovio Pharmaceuticals in the Nexus archive.

Earliest in view: Jun 8 · 16:41 UTCMost recent: Jun 8 · 16:41 UTC
Co-mentioned in this coverage
Californiaplace1Gavin Newsomperson1life sciences industrytopic1tech industrytopic1Robert Rivasperson1Monique Limonperson1Legislative Analyst’s Officeorganization1
Recent coverage
  • BUSINESSJun 8 · 16:41 UTCLAIST
    California wants to cap business tax credits, alarming life sciences and tech industries

    California’s proposed cap on corporate tax credits, set to take effect in 2027, has drawn opposition from the life sciences and tech industries, which argue it would threaten their economic contributions and innovation. The policy aims to ensure large corporations pay minimum taxes while lawmakers debate its impact on state revenue and business incentives.

Inovio Pharmaceuticals · Dossier · The Nexus